nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—Sorafenib—kidney cancer	0.587	1	CrCtD
Vismodegib—ABCB1—kidney cancer	0.0665	1	CbGaD
Vismodegib—ORM1—Erlotinib—kidney cancer	0.0185	0.0795	CbGbCtD
Vismodegib—ABCG2—Pazopanib—kidney cancer	0.0158	0.068	CbGbCtD
Vismodegib—ABCG2—Dactinomycin—kidney cancer	0.0144	0.0622	CbGbCtD
Vismodegib—ABCG2—Erlotinib—kidney cancer	0.0113	0.0485	CbGbCtD
Vismodegib—ABCB1—Temsirolimus—kidney cancer	0.0108	0.0467	CbGbCtD
Vismodegib—ABCG2—Paclitaxel—kidney cancer	0.0103	0.0444	CbGbCtD
Vismodegib—CYP3A4—Everolimus—kidney cancer	0.00961	0.0414	CbGbCtD
Vismodegib—ABCG2—Sorafenib—kidney cancer	0.00916	0.0395	CbGbCtD
Vismodegib—ABCG2—Vincristine—kidney cancer	0.00889	0.0383	CbGbCtD
Vismodegib—CYP2C8—Pazopanib—kidney cancer	0.00841	0.0362	CbGbCtD
Vismodegib—ALB—Erlotinib—kidney cancer	0.00776	0.0335	CbGbCtD
Vismodegib—ABCG2—Sunitinib—kidney cancer	0.00742	0.032	CbGbCtD
Vismodegib—CYP3A4—Temsirolimus—kidney cancer	0.00649	0.028	CbGbCtD
Vismodegib—CYP2C9—Capecitabine—kidney cancer	0.00612	0.0264	CbGbCtD
Vismodegib—CYP2C8—Erlotinib—kidney cancer	0.006	0.0259	CbGbCtD
Vismodegib—ABCB1—Pazopanib—kidney cancer	0.00569	0.0245	CbGbCtD
Vismodegib—ABCG2—Doxorubicin—kidney cancer	0.00556	0.0239	CbGbCtD
Vismodegib—CYP2C8—Paclitaxel—kidney cancer	0.00549	0.0237	CbGbCtD
Vismodegib—ABCB1—Dactinomycin—kidney cancer	0.0052	0.0224	CbGbCtD
Vismodegib—CYP2C8—Sorafenib—kidney cancer	0.00488	0.021	CbGbCtD
Vismodegib—ABCB1—Gemcitabine—kidney cancer	0.00411	0.0177	CbGbCtD
Vismodegib—CYP2C19—Sorafenib—kidney cancer	0.00409	0.0176	CbGbCtD
Vismodegib—ABCB1—Erlotinib—kidney cancer	0.00406	0.0175	CbGbCtD
Vismodegib—CYP2C9—Paclitaxel—kidney cancer	0.00383	0.0165	CbGbCtD
Vismodegib—ABCB1—Paclitaxel—kidney cancer	0.00372	0.016	CbGbCtD
Vismodegib—CYP3A4—Pazopanib—kidney cancer	0.00341	0.0147	CbGbCtD
Vismodegib—CYP2C9—Sorafenib—kidney cancer	0.0034	0.0147	CbGbCtD
Vismodegib—ABCB1—Sorafenib—kidney cancer	0.0033	0.0142	CbGbCtD
Vismodegib—ABCB1—Vinblastine—kidney cancer	0.00326	0.014	CbGbCtD
Vismodegib—ABCB1—Vincristine—kidney cancer	0.00321	0.0138	CbGbCtD
Vismodegib—ABCB1—Sunitinib—kidney cancer	0.00268	0.0115	CbGbCtD
Vismodegib—CYP3A4—Erlotinib—kidney cancer	0.00243	0.0105	CbGbCtD
Vismodegib—CYP3A4—Paclitaxel—kidney cancer	0.00223	0.0096	CbGbCtD
Vismodegib—ABCB1—Doxorubicin—kidney cancer	0.002	0.00863	CbGbCtD
Vismodegib—CYP3A4—Sorafenib—kidney cancer	0.00198	0.00852	CbGbCtD
Vismodegib—CYP3A4—Vinblastine—kidney cancer	0.00195	0.00842	CbGbCtD
Vismodegib—CYP3A4—Vincristine—kidney cancer	0.00192	0.00828	CbGbCtD
Vismodegib—CYP3A4—Sunitinib—kidney cancer	0.0016	0.00691	CbGbCtD
Vismodegib—CYP3A4—Doxorubicin—kidney cancer	0.0012	0.00517	CbGbCtD
Vismodegib—SHH—renal system—kidney cancer	0.00102	0.151	CbGeAlD
Vismodegib—SHH—kidney—kidney cancer	0.000987	0.146	CbGeAlD
Vismodegib—CYP2C19—urine—kidney cancer	0.0009	0.134	CbGeAlD
Vismodegib—CYP2C9—urine—kidney cancer	0.000698	0.104	CbGeAlD
Vismodegib—SMO—cortex of kidney—kidney cancer	0.000672	0.0997	CbGeAlD
Vismodegib—SMO—cardiac atrium—kidney cancer	0.000639	0.0948	CbGeAlD
Vismodegib—CYP3A4—urine—kidney cancer	0.000532	0.079	CbGeAlD
Vismodegib—Sorafenib—RAF1—kidney cancer	0.000478	0.203	CrCbGaD
Vismodegib—Sorafenib—FLT1—kidney cancer	0.000449	0.191	CrCbGaD
Vismodegib—Sorafenib—BRAF—kidney cancer	0.000331	0.141	CrCbGaD
Vismodegib—Sorafenib—KDR—kidney cancer	0.000282	0.12	CrCbGaD
Vismodegib—Sorafenib—KIT—kidney cancer	0.000266	0.113	CrCbGaD
Vismodegib—ABCG2—nephron tubule—kidney cancer	0.000206	0.0305	CbGeAlD
Vismodegib—CYP2C8—renal system—kidney cancer	0.000192	0.0285	CbGeAlD
Vismodegib—CYP2C8—kidney—kidney cancer	0.000186	0.0276	CbGeAlD
Vismodegib—Tolvaptan—ABCB1—kidney cancer	0.000145	0.0618	CrCbGaD
Vismodegib—Sulfasalazine—PTGS1—kidney cancer	0.000134	0.0568	CrCbGaD
Vismodegib—CYP3A4—renal system—kidney cancer	0.00013	0.0193	CbGeAlD
Vismodegib—Etoricoxib—PTGS2—kidney cancer	0.00013	0.0551	CrCbGaD
Vismodegib—CYP3A4—kidney—kidney cancer	0.000126	0.0187	CbGeAlD
Vismodegib—Nervous system disorder—Erlotinib—kidney cancer	0.000106	0.00142	CcSEcCtD
Vismodegib—Hyponatraemia—Capecitabine—kidney cancer	0.000105	0.00141	CcSEcCtD
Vismodegib—Skin disorder—Erlotinib—kidney cancer	0.000105	0.00141	CcSEcCtD
Vismodegib—Pain in extremity—Capecitabine—kidney cancer	0.000105	0.00141	CcSEcCtD
Vismodegib—Connective tissue disorder—Gemcitabine—kidney cancer	0.000104	0.00139	CcSEcCtD
Vismodegib—Diarrhoea—Temsirolimus—kidney cancer	0.000103	0.00138	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000102	0.00137	CcSEcCtD
Vismodegib—Asthenia—Pazopanib—kidney cancer	0.000102	0.00137	CcSEcCtD
Vismodegib—ABCB1—nephron tubule—kidney cancer	0.000101	0.015	CbGeAlD
Vismodegib—Myalgia—Sorafenib—kidney cancer	0.000101	0.00136	CcSEcCtD
Vismodegib—Arthralgia—Sorafenib—kidney cancer	0.000101	0.00136	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000101	0.00135	CcSEcCtD
Vismodegib—Pruritus—Pazopanib—kidney cancer	0.0001	0.00135	CcSEcCtD
Vismodegib—Weight decreased—Paclitaxel—kidney cancer	9.99e-05	0.00134	CcSEcCtD
Vismodegib—Dyspepsia—Everolimus—kidney cancer	9.85e-05	0.00132	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Erlotinib—kidney cancer	9.83e-05	0.00132	CcSEcCtD
Vismodegib—Alopecia—Vincristine—kidney cancer	9.83e-05	0.00132	CcSEcCtD
Vismodegib—Decreased appetite—Vinblastine—kidney cancer	9.76e-05	0.00131	CcSEcCtD
Vismodegib—Myalgia—Sunitinib—kidney cancer	9.75e-05	0.00131	CcSEcCtD
Vismodegib—Arthralgia—Sunitinib—kidney cancer	9.75e-05	0.00131	CcSEcCtD
Vismodegib—Dehydration—Capecitabine—kidney cancer	9.75e-05	0.00131	CcSEcCtD
Vismodegib—Decreased appetite—Everolimus—kidney cancer	9.72e-05	0.00131	CcSEcCtD
Vismodegib—Diarrhoea—Pazopanib—kidney cancer	9.69e-05	0.0013	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	9.68e-05	0.0013	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Everolimus—kidney cancer	9.66e-05	0.0013	CcSEcCtD
Vismodegib—Fatigue—Everolimus—kidney cancer	9.64e-05	0.0013	CcSEcCtD
Vismodegib—Pain—Vinblastine—kidney cancer	9.6e-05	0.00129	CcSEcCtD
Vismodegib—Constipation—Vinblastine—kidney cancer	9.6e-05	0.00129	CcSEcCtD
Vismodegib—Abdominal pain upper—Capecitabine—kidney cancer	9.57e-05	0.00129	CcSEcCtD
Vismodegib—Constipation—Everolimus—kidney cancer	9.57e-05	0.00129	CcSEcCtD
Vismodegib—Pain—Everolimus—kidney cancer	9.57e-05	0.00129	CcSEcCtD
Vismodegib—Vomiting—Temsirolimus—kidney cancer	9.56e-05	0.00129	CcSEcCtD
Vismodegib—Hypokalaemia—Capecitabine—kidney cancer	9.54e-05	0.00128	CcSEcCtD
Vismodegib—Nervous system disorder—Sorafenib—kidney cancer	9.52e-05	0.00128	CcSEcCtD
Vismodegib—Dyspepsia—Erlotinib—kidney cancer	9.5e-05	0.00128	CcSEcCtD
Vismodegib—Rash—Temsirolimus—kidney cancer	9.48e-05	0.00127	CcSEcCtD
Vismodegib—Dermatitis—Temsirolimus—kidney cancer	9.47e-05	0.00127	CcSEcCtD
Vismodegib—Breast disorder—Capecitabine—kidney cancer	9.47e-05	0.00127	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Capecitabine—kidney cancer	9.44e-05	0.00127	CcSEcCtD
Vismodegib—Skin disorder—Sorafenib—kidney cancer	9.43e-05	0.00127	CcSEcCtD
Vismodegib—Musculoskeletal pain—Doxorubicin—kidney cancer	9.42e-05	0.00127	CcSEcCtD
Vismodegib—Decreased appetite—Erlotinib—kidney cancer	9.38e-05	0.00126	CcSEcCtD
Vismodegib—Back pain—Vincristine—kidney cancer	9.37e-05	0.00126	CcSEcCtD
Vismodegib—Alopecia—Gemcitabine—kidney cancer	9.33e-05	0.00125	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Erlotinib—kidney cancer	9.32e-05	0.00125	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Doxorubicin—kidney cancer	9.31e-05	0.00125	CcSEcCtD
Vismodegib—Fatigue—Erlotinib—kidney cancer	9.31e-05	0.00125	CcSEcCtD
Vismodegib—Constipation—Erlotinib—kidney cancer	9.23e-05	0.00124	CcSEcCtD
Vismodegib—Pain—Erlotinib—kidney cancer	9.23e-05	0.00124	CcSEcCtD
Vismodegib—Myalgia—Dactinomycin—kidney cancer	9.23e-05	0.00124	CcSEcCtD
Vismodegib—ABCB1—renal system—kidney cancer	9.22e-05	0.0137	CbGeAlD
Vismodegib—Gastrointestinal pain—Vinblastine—kidney cancer	9.18e-05	0.00123	CcSEcCtD
Vismodegib—Nervous system disorder—Sunitinib—kidney cancer	9.16e-05	0.00123	CcSEcCtD
Vismodegib—Gastrointestinal pain—Everolimus—kidney cancer	9.15e-05	0.00123	CcSEcCtD
Vismodegib—Skin disorder—Sunitinib—kidney cancer	9.08e-05	0.00122	CcSEcCtD
Vismodegib—Vomiting—Pazopanib—kidney cancer	9.01e-05	0.00121	CcSEcCtD
Vismodegib—Rash—Pazopanib—kidney cancer	8.93e-05	0.0012	CcSEcCtD
Vismodegib—Nausea—Temsirolimus—kidney cancer	8.93e-05	0.0012	CcSEcCtD
Vismodegib—Dermatitis—Pazopanib—kidney cancer	8.92e-05	0.0012	CcSEcCtD
Vismodegib—ABCB1—kidney—kidney cancer	8.91e-05	0.0132	CbGeAlD
Vismodegib—Back pain—Gemcitabine—kidney cancer	8.89e-05	0.00119	CcSEcCtD
Vismodegib—Abdominal pain—Vinblastine—kidney cancer	8.88e-05	0.00119	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Sorafenib—kidney cancer	8.85e-05	0.00119	CcSEcCtD
Vismodegib—Abdominal pain—Everolimus—kidney cancer	8.84e-05	0.00119	CcSEcCtD
Vismodegib—Gastrointestinal pain—Erlotinib—kidney cancer	8.83e-05	0.00119	CcSEcCtD
Vismodegib—Blood urea increased—Doxorubicin—kidney cancer	8.79e-05	0.00118	CcSEcCtD
Vismodegib—Connective tissue disorder—Paclitaxel—kidney cancer	8.68e-05	0.00117	CcSEcCtD
Vismodegib—ABCB1—cortex of kidney—kidney cancer	8.68e-05	0.0129	CbGeAlD
Vismodegib—Dyspepsia—Sorafenib—kidney cancer	8.55e-05	0.00115	CcSEcCtD
Vismodegib—Abdominal pain—Erlotinib—kidney cancer	8.53e-05	0.00115	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Sunitinib—kidney cancer	8.51e-05	0.00114	CcSEcCtD
Vismodegib—Decreased appetite—Sorafenib—kidney cancer	8.44e-05	0.00113	CcSEcCtD
Vismodegib—Nausea—Pazopanib—kidney cancer	8.42e-05	0.00113	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Sorafenib—kidney cancer	8.38e-05	0.00113	CcSEcCtD
Vismodegib—Fatigue—Sorafenib—kidney cancer	8.37e-05	0.00113	CcSEcCtD
Vismodegib—Pain—Sorafenib—kidney cancer	8.3e-05	0.00112	CcSEcCtD
Vismodegib—Constipation—Sorafenib—kidney cancer	8.3e-05	0.00112	CcSEcCtD
Vismodegib—ABCB1—gonad—kidney cancer	8.27e-05	0.0123	CbGeAlD
Vismodegib—Myalgia—Vincristine—kidney cancer	8.24e-05	0.00111	CcSEcCtD
Vismodegib—Dyspepsia—Sunitinib—kidney cancer	8.22e-05	0.00111	CcSEcCtD
Vismodegib—Weight decreased—Capecitabine—kidney cancer	8.2e-05	0.0011	CcSEcCtD
Vismodegib—Decreased appetite—Sunitinib—kidney cancer	8.12e-05	0.00109	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Sunitinib—kidney cancer	8.07e-05	0.00108	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dactinomycin—kidney cancer	8.06e-05	0.00108	CcSEcCtD
Vismodegib—Asthenia—Vinblastine—kidney cancer	8.06e-05	0.00108	CcSEcCtD
Vismodegib—Fatigue—Sunitinib—kidney cancer	8.06e-05	0.00108	CcSEcCtD
Vismodegib—Asthenia—Everolimus—kidney cancer	8.03e-05	0.00108	CcSEcCtD
Vismodegib—Constipation—Sunitinib—kidney cancer	7.99e-05	0.00107	CcSEcCtD
Vismodegib—Pain—Sunitinib—kidney cancer	7.99e-05	0.00107	CcSEcCtD
Vismodegib—Gastrointestinal pain—Sorafenib—kidney cancer	7.94e-05	0.00107	CcSEcCtD
Vismodegib—Pruritus—Everolimus—kidney cancer	7.91e-05	0.00106	CcSEcCtD
Vismodegib—Arthralgia—Gemcitabine—kidney cancer	7.82e-05	0.00105	CcSEcCtD
Vismodegib—Myalgia—Gemcitabine—kidney cancer	7.82e-05	0.00105	CcSEcCtD
Vismodegib—Alopecia—Paclitaxel—kidney cancer	7.81e-05	0.00105	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	7.77e-05	0.00104	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	7.77e-05	0.00104	CcSEcCtD
Vismodegib—Nervous system disorder—Vincristine—kidney cancer	7.75e-05	0.00104	CcSEcCtD
Vismodegib—Asthenia—Erlotinib—kidney cancer	7.74e-05	0.00104	CcSEcCtD
Vismodegib—Malnutrition—Paclitaxel—kidney cancer	7.69e-05	0.00103	CcSEcCtD
Vismodegib—Decreased appetite—Dactinomycin—kidney cancer	7.69e-05	0.00103	CcSEcCtD
Vismodegib—Diarrhoea—Vinblastine—kidney cancer	7.68e-05	0.00103	CcSEcCtD
Vismodegib—Abdominal pain—Sorafenib—kidney cancer	7.68e-05	0.00103	CcSEcCtD
Vismodegib—Diarrhoea—Everolimus—kidney cancer	7.65e-05	0.00103	CcSEcCtD
Vismodegib—Gastrointestinal pain—Sunitinib—kidney cancer	7.64e-05	0.00103	CcSEcCtD
Vismodegib—Pruritus—Erlotinib—kidney cancer	7.64e-05	0.00103	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—kidney cancer	7.63e-05	0.0325	CrCbGaD
Vismodegib—Fatigue—Dactinomycin—kidney cancer	7.63e-05	0.00102	CcSEcCtD
Vismodegib—Pain—Dactinomycin—kidney cancer	7.56e-05	0.00102	CcSEcCtD
Vismodegib—Dysgeusia—Paclitaxel—kidney cancer	7.53e-05	0.00101	CcSEcCtD
Vismodegib—Back pain—Paclitaxel—kidney cancer	7.44e-05	0.001	CcSEcCtD
Vismodegib—Muscle spasms—Paclitaxel—kidney cancer	7.39e-05	0.000994	CcSEcCtD
Vismodegib—Abdominal pain—Sunitinib—kidney cancer	7.39e-05	0.000993	CcSEcCtD
Vismodegib—Diarrhoea—Erlotinib—kidney cancer	7.39e-05	0.000993	CcSEcCtD
Vismodegib—Nervous system disorder—Gemcitabine—kidney cancer	7.35e-05	0.000988	CcSEcCtD
Vismodegib—Skin disorder—Gemcitabine—kidney cancer	7.28e-05	0.000979	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dactinomycin—kidney cancer	7.23e-05	0.000972	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Vincristine—kidney cancer	7.2e-05	0.000968	CcSEcCtD
Vismodegib—Vomiting—Vinblastine—kidney cancer	7.14e-05	0.00096	CcSEcCtD
Vismodegib—Connective tissue disorder—Capecitabine—kidney cancer	7.12e-05	0.000958	CcSEcCtD
Vismodegib—Vomiting—Everolimus—kidney cancer	7.11e-05	0.000956	CcSEcCtD
Vismodegib—Rash—Everolimus—kidney cancer	7.05e-05	0.000948	CcSEcCtD
Vismodegib—Dermatitis—Everolimus—kidney cancer	7.05e-05	0.000947	CcSEcCtD
Vismodegib—Abdominal pain—Dactinomycin—kidney cancer	6.99e-05	0.00094	CcSEcCtD
Vismodegib—Asthenia—Sorafenib—kidney cancer	6.97e-05	0.000936	CcSEcCtD
Vismodegib—Decreased appetite—Vincristine—kidney cancer	6.87e-05	0.000923	CcSEcCtD
Vismodegib—Pruritus—Sorafenib—kidney cancer	6.87e-05	0.000923	CcSEcCtD
Vismodegib—Vomiting—Erlotinib—kidney cancer	6.86e-05	0.000922	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Gemcitabine—kidney cancer	6.83e-05	0.000918	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Vincristine—kidney cancer	6.82e-05	0.000917	CcSEcCtD
Vismodegib—Fatigue—Vincristine—kidney cancer	6.81e-05	0.000916	CcSEcCtD
Vismodegib—Rash—Erlotinib—kidney cancer	6.81e-05	0.000915	CcSEcCtD
Vismodegib—Dermatitis—Erlotinib—kidney cancer	6.8e-05	0.000914	CcSEcCtD
Vismodegib—Hyponatraemia—Doxorubicin—kidney cancer	6.78e-05	0.000912	CcSEcCtD
Vismodegib—Pain—Vincristine—kidney cancer	6.76e-05	0.000908	CcSEcCtD
Vismodegib—Constipation—Vincristine—kidney cancer	6.76e-05	0.000908	CcSEcCtD
Vismodegib—Pain in extremity—Doxorubicin—kidney cancer	6.76e-05	0.000908	CcSEcCtD
Vismodegib—Asthenia—Sunitinib—kidney cancer	6.7e-05	0.000901	CcSEcCtD
Vismodegib—Nausea—Vinblastine—kidney cancer	6.67e-05	0.000897	CcSEcCtD
Vismodegib—Nausea—Everolimus—kidney cancer	6.64e-05	0.000893	CcSEcCtD
Vismodegib—Diarrhoea—Sorafenib—kidney cancer	6.64e-05	0.000893	CcSEcCtD
Vismodegib—Pruritus—Sunitinib—kidney cancer	6.61e-05	0.000888	CcSEcCtD
Vismodegib—Myalgia—Paclitaxel—kidney cancer	6.55e-05	0.00088	CcSEcCtD
Vismodegib—Arthralgia—Paclitaxel—kidney cancer	6.55e-05	0.00088	CcSEcCtD
Vismodegib—Decreased appetite—Gemcitabine—kidney cancer	6.52e-05	0.000876	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	6.5e-05	0.000874	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Gemcitabine—kidney cancer	6.47e-05	0.00087	CcSEcCtD
Vismodegib—Fatigue—Gemcitabine—kidney cancer	6.46e-05	0.000869	CcSEcCtD
Vismodegib—Gastrointestinal pain—Vincristine—kidney cancer	6.46e-05	0.000869	CcSEcCtD
Vismodegib—Constipation—Gemcitabine—kidney cancer	6.41e-05	0.000862	CcSEcCtD
Vismodegib—Pain—Gemcitabine—kidney cancer	6.41e-05	0.000862	CcSEcCtD
Vismodegib—Nausea—Erlotinib—kidney cancer	6.41e-05	0.000862	CcSEcCtD
Vismodegib—Alopecia—Capecitabine—kidney cancer	6.41e-05	0.000861	CcSEcCtD
Vismodegib—Diarrhoea—Sunitinib—kidney cancer	6.39e-05	0.000859	CcSEcCtD
Vismodegib—Asthenia—Dactinomycin—kidney cancer	6.35e-05	0.000853	CcSEcCtD
Vismodegib—Malnutrition—Capecitabine—kidney cancer	6.31e-05	0.000848	CcSEcCtD
Vismodegib—Dehydration—Doxorubicin—kidney cancer	6.28e-05	0.000844	CcSEcCtD
Vismodegib—Abdominal pain—Vincristine—kidney cancer	6.25e-05	0.00084	CcSEcCtD
Vismodegib—Dysgeusia—Capecitabine—kidney cancer	6.18e-05	0.000831	CcSEcCtD
Vismodegib—Vomiting—Sorafenib—kidney cancer	6.17e-05	0.00083	CcSEcCtD
Vismodegib—Abdominal pain upper—Doxorubicin—kidney cancer	6.17e-05	0.000829	CcSEcCtD
Vismodegib—Nervous system disorder—Paclitaxel—kidney cancer	6.16e-05	0.000827	CcSEcCtD
Vismodegib—Hypokalaemia—Doxorubicin—kidney cancer	6.15e-05	0.000826	CcSEcCtD
Vismodegib—Sorafenib—ABCB1—kidney cancer	6.13e-05	0.026	CrCbGaD
Vismodegib—Rash—Sorafenib—kidney cancer	6.12e-05	0.000823	CcSEcCtD
Vismodegib—Dermatitis—Sorafenib—kidney cancer	6.12e-05	0.000822	CcSEcCtD
Vismodegib—Back pain—Capecitabine—kidney cancer	6.11e-05	0.000821	CcSEcCtD
Vismodegib—Breast disorder—Doxorubicin—kidney cancer	6.11e-05	0.000821	CcSEcCtD
Vismodegib—Skin disorder—Paclitaxel—kidney cancer	6.1e-05	0.000819	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.08e-05	0.000818	CcSEcCtD
Vismodegib—Muscle spasms—Capecitabine—kidney cancer	6.07e-05	0.000816	CcSEcCtD
Vismodegib—Diarrhoea—Dactinomycin—kidney cancer	6.05e-05	0.000813	CcSEcCtD
Vismodegib—Vomiting—Sunitinib—kidney cancer	5.94e-05	0.000798	CcSEcCtD
Vismodegib—Rash—Sunitinib—kidney cancer	5.89e-05	0.000792	CcSEcCtD
Vismodegib—Dermatitis—Sunitinib—kidney cancer	5.89e-05	0.000791	CcSEcCtD
Vismodegib—Nausea—Sorafenib—kidney cancer	5.77e-05	0.000775	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.72e-05	0.000769	CcSEcCtD
Vismodegib—Asthenia—Vincristine—kidney cancer	5.67e-05	0.000762	CcSEcCtD
Vismodegib—Vomiting—Dactinomycin—kidney cancer	5.62e-05	0.000756	CcSEcCtD
Vismodegib—Rash—Dactinomycin—kidney cancer	5.58e-05	0.00075	CcSEcCtD
Vismodegib—Nausea—Sunitinib—kidney cancer	5.55e-05	0.000746	CcSEcCtD
Vismodegib—Dyspepsia—Paclitaxel—kidney cancer	5.53e-05	0.000743	CcSEcCtD
Vismodegib—Decreased appetite—Paclitaxel—kidney cancer	5.46e-05	0.000733	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.42e-05	0.000728	CcSEcCtD
Vismodegib—Fatigue—Paclitaxel—kidney cancer	5.41e-05	0.000727	CcSEcCtD
Vismodegib—Diarrhoea—Vincristine—kidney cancer	5.41e-05	0.000727	CcSEcCtD
Vismodegib—Asthenia—Gemcitabine—kidney cancer	5.38e-05	0.000723	CcSEcCtD
Vismodegib—Arthralgia—Capecitabine—kidney cancer	5.37e-05	0.000722	CcSEcCtD
Vismodegib—Myalgia—Capecitabine—kidney cancer	5.37e-05	0.000722	CcSEcCtD
Vismodegib—Constipation—Paclitaxel—kidney cancer	5.37e-05	0.000721	CcSEcCtD
Vismodegib—Pain—Paclitaxel—kidney cancer	5.37e-05	0.000721	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.34e-05	0.000717	CcSEcCtD
Vismodegib—Pruritus—Gemcitabine—kidney cancer	5.3e-05	0.000713	CcSEcCtD
Vismodegib—Weight decreased—Doxorubicin—kidney cancer	5.28e-05	0.00071	CcSEcCtD
Vismodegib—Nausea—Dactinomycin—kidney cancer	5.25e-05	0.000706	CcSEcCtD
Vismodegib—Gastrointestinal pain—Paclitaxel—kidney cancer	5.13e-05	0.00069	CcSEcCtD
Vismodegib—Diarrhoea—Gemcitabine—kidney cancer	5.13e-05	0.000689	CcSEcCtD
Vismodegib—Nervous system disorder—Capecitabine—kidney cancer	5.05e-05	0.000679	CcSEcCtD
Vismodegib—Vomiting—Vincristine—kidney cancer	5.02e-05	0.000675	CcSEcCtD
Vismodegib—Skin disorder—Capecitabine—kidney cancer	5e-05	0.000672	CcSEcCtD
Vismodegib—Rash—Vincristine—kidney cancer	4.98e-05	0.00067	CcSEcCtD
Vismodegib—Dermatitis—Vincristine—kidney cancer	4.98e-05	0.000669	CcSEcCtD
Vismodegib—Abdominal pain—Paclitaxel—kidney cancer	4.96e-05	0.000667	CcSEcCtD
Vismodegib—Vomiting—Gemcitabine—kidney cancer	4.77e-05	0.000641	CcSEcCtD
Vismodegib—Rash—Gemcitabine—kidney cancer	4.73e-05	0.000635	CcSEcCtD
Vismodegib—Dermatitis—Gemcitabine—kidney cancer	4.72e-05	0.000635	CcSEcCtD
Vismodegib—Nausea—Vincristine—kidney cancer	4.69e-05	0.000631	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.69e-05	0.000631	CcSEcCtD
Vismodegib—Connective tissue disorder—Doxorubicin—kidney cancer	4.59e-05	0.000617	CcSEcCtD
Vismodegib—Dyspepsia—Capecitabine—kidney cancer	4.53e-05	0.000609	CcSEcCtD
Vismodegib—Asthenia—Paclitaxel—kidney cancer	4.5e-05	0.000605	CcSEcCtD
Vismodegib—Decreased appetite—Capecitabine—kidney cancer	4.48e-05	0.000602	CcSEcCtD
Vismodegib—Nausea—Gemcitabine—kidney cancer	4.45e-05	0.000599	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Capecitabine—kidney cancer	4.45e-05	0.000598	CcSEcCtD
Vismodegib—Fatigue—Capecitabine—kidney cancer	4.44e-05	0.000597	CcSEcCtD
Vismodegib—Pruritus—Paclitaxel—kidney cancer	4.44e-05	0.000597	CcSEcCtD
Vismodegib—Pain—Capecitabine—kidney cancer	4.41e-05	0.000592	CcSEcCtD
Vismodegib—Constipation—Capecitabine—kidney cancer	4.41e-05	0.000592	CcSEcCtD
Vismodegib—Diarrhoea—Paclitaxel—kidney cancer	4.29e-05	0.000577	CcSEcCtD
Vismodegib—Gastrointestinal pain—Capecitabine—kidney cancer	4.21e-05	0.000566	CcSEcCtD
Vismodegib—Alopecia—Doxorubicin—kidney cancer	4.13e-05	0.000555	CcSEcCtD
Vismodegib—Abdominal pain—Capecitabine—kidney cancer	4.07e-05	0.000547	CcSEcCtD
Vismodegib—Malnutrition—Doxorubicin—kidney cancer	4.07e-05	0.000547	CcSEcCtD
Vismodegib—Vomiting—Paclitaxel—kidney cancer	3.99e-05	0.000536	CcSEcCtD
Vismodegib—Dysgeusia—Doxorubicin—kidney cancer	3.98e-05	0.000535	CcSEcCtD
Vismodegib—Rash—Paclitaxel—kidney cancer	3.96e-05	0.000532	CcSEcCtD
Vismodegib—Dermatitis—Paclitaxel—kidney cancer	3.95e-05	0.000531	CcSEcCtD
Vismodegib—Back pain—Doxorubicin—kidney cancer	3.94e-05	0.000529	CcSEcCtD
Vismodegib—Muscle spasms—Doxorubicin—kidney cancer	3.91e-05	0.000526	CcSEcCtD
Vismodegib—Nausea—Paclitaxel—kidney cancer	3.73e-05	0.000501	CcSEcCtD
Vismodegib—Asthenia—Capecitabine—kidney cancer	3.7e-05	0.000497	CcSEcCtD
Vismodegib—Pruritus—Capecitabine—kidney cancer	3.64e-05	0.00049	CcSEcCtD
Vismodegib—Diarrhoea—Capecitabine—kidney cancer	3.52e-05	0.000474	CcSEcCtD
Vismodegib—Myalgia—Doxorubicin—kidney cancer	3.46e-05	0.000466	CcSEcCtD
Vismodegib—Arthralgia—Doxorubicin—kidney cancer	3.46e-05	0.000466	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.44e-05	0.000462	CcSEcCtD
Vismodegib—Vomiting—Capecitabine—kidney cancer	3.28e-05	0.00044	CcSEcCtD
Vismodegib—Nervous system disorder—Doxorubicin—kidney cancer	3.26e-05	0.000438	CcSEcCtD
Vismodegib—Rash—Capecitabine—kidney cancer	3.25e-05	0.000437	CcSEcCtD
Vismodegib—Dermatitis—Capecitabine—kidney cancer	3.24e-05	0.000436	CcSEcCtD
Vismodegib—Skin disorder—Doxorubicin—kidney cancer	3.23e-05	0.000433	CcSEcCtD
Vismodegib—Nausea—Capecitabine—kidney cancer	3.06e-05	0.000411	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.03e-05	0.000407	CcSEcCtD
Vismodegib—Dyspepsia—Doxorubicin—kidney cancer	2.92e-05	0.000393	CcSEcCtD
Vismodegib—Decreased appetite—Doxorubicin—kidney cancer	2.89e-05	0.000388	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.87e-05	0.000385	CcSEcCtD
Vismodegib—Fatigue—Doxorubicin—kidney cancer	2.86e-05	0.000385	CcSEcCtD
Vismodegib—Pain—Doxorubicin—kidney cancer	2.84e-05	0.000382	CcSEcCtD
Vismodegib—Constipation—Doxorubicin—kidney cancer	2.84e-05	0.000382	CcSEcCtD
Vismodegib—Gastrointestinal pain—Doxorubicin—kidney cancer	2.72e-05	0.000365	CcSEcCtD
Vismodegib—Abdominal pain—Doxorubicin—kidney cancer	2.62e-05	0.000353	CcSEcCtD
Vismodegib—Asthenia—Doxorubicin—kidney cancer	2.38e-05	0.00032	CcSEcCtD
Vismodegib—Pruritus—Doxorubicin—kidney cancer	2.35e-05	0.000316	CcSEcCtD
Vismodegib—Diarrhoea—Doxorubicin—kidney cancer	2.27e-05	0.000305	CcSEcCtD
Vismodegib—Vomiting—Doxorubicin—kidney cancer	2.11e-05	0.000284	CcSEcCtD
Vismodegib—Rash—Doxorubicin—kidney cancer	2.09e-05	0.000281	CcSEcCtD
Vismodegib—Dermatitis—Doxorubicin—kidney cancer	2.09e-05	0.000281	CcSEcCtD
Vismodegib—Nausea—Doxorubicin—kidney cancer	1.97e-05	0.000265	CcSEcCtD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.91e-06	0.000222	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.88e-06	0.000221	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALDH1A1—kidney cancer	6.83e-06	0.00022	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ALDH1A1—kidney cancer	6.8e-06	0.000218	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.76e-06	0.000217	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PTEN—kidney cancer	6.75e-06	0.000217	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPC3—kidney cancer	6.75e-06	0.000217	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ACY1—kidney cancer	6.69e-06	0.000215	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF2—kidney cancer	6.64e-06	0.000214	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPC3—kidney cancer	6.58e-06	0.000212	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA2—kidney cancer	6.56e-06	0.000211	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PGK1—kidney cancer	6.55e-06	0.000211	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC5A3—kidney cancer	6.55e-06	0.000211	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—FH—kidney cancer	6.54e-06	0.00021	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APRT—kidney cancer	6.54e-06	0.00021	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC5A3—kidney cancer	6.51e-06	0.000209	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PGK1—kidney cancer	6.51e-06	0.000209	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTT1—kidney cancer	6.47e-06	0.000208	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ACHE—kidney cancer	6.47e-06	0.000208	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—kidney cancer	6.43e-06	0.000207	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.43e-06	0.000207	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—LDHB—kidney cancer	6.43e-06	0.000207	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA2—kidney cancer	6.4e-06	0.000206	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.4e-06	0.000206	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALAD—kidney cancer	6.39e-06	0.000206	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.39e-06	0.000206	CbGpPWpGaD
Vismodegib—ALB—Metabolism—LDHB—kidney cancer	6.39e-06	0.000205	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	6.36e-06	0.000204	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ST3GAL2—kidney cancer	6.24e-06	0.000201	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALAD—kidney cancer	6.24e-06	0.000201	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.21e-06	0.0002	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPC3—kidney cancer	6.15e-06	0.000198	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SCARB1—kidney cancer	6.13e-06	0.000197	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.1e-06	0.000196	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALDH1A1—kidney cancer	6.1e-06	0.000196	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—kidney cancer	6.1e-06	0.000196	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ST3GAL2—kidney cancer	6.09e-06	0.000196	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.09e-06	0.000196	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAPK3—kidney cancer	6.08e-06	0.000196	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS1—kidney cancer	6.06e-06	0.000195	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.04e-06	0.000194	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA2—kidney cancer	5.98e-06	0.000192	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALDH1A1—kidney cancer	5.95e-06	0.000191	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PSMD7—kidney cancer	5.95e-06	0.000191	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MYC—kidney cancer	5.92e-06	0.00019	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.89e-06	0.000189	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PGK1—kidney cancer	5.85e-06	0.000188	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.85e-06	0.000188	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALAD—kidney cancer	5.83e-06	0.000187	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAPK1—kidney cancer	5.79e-06	0.000186	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAPK3—kidney cancer	5.77e-06	0.000185	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—LDHB—kidney cancer	5.74e-06	0.000184	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PGK1—kidney cancer	5.71e-06	0.000184	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC5A3—kidney cancer	5.71e-06	0.000184	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PDHB—kidney cancer	5.69e-06	0.000183	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ST3GAL2—kidney cancer	5.69e-06	0.000183	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—kidney cancer	5.67e-06	0.000182	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—BCHE—kidney cancer	5.64e-06	0.000181	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MYC—kidney cancer	5.61e-06	0.00018	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—LDHB—kidney cancer	5.6e-06	0.00018	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.59e-06	0.00018	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA9—kidney cancer	5.57e-06	0.000179	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC5A5—kidney cancer	5.57e-06	0.000179	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALDH1A1—kidney cancer	5.56e-06	0.000179	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA9—kidney cancer	5.54e-06	0.000178	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAPK1—kidney cancer	5.49e-06	0.000176	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—KRAS—kidney cancer	5.47e-06	0.000176	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.45e-06	0.000175	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.41e-06	0.000174	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	5.4e-06	0.000174	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC2A1—kidney cancer	5.38e-06	0.000173	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CCBL1—kidney cancer	5.35e-06	0.000172	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PGK1—kidney cancer	5.33e-06	0.000171	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.33e-06	0.000171	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.32e-06	0.000171	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LDHB—kidney cancer	5.23e-06	0.000168	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KRAS—kidney cancer	5.18e-06	0.000167	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	5.13e-06	0.000165	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	5.11e-06	0.000164	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.03e-06	0.000162	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PIK3CA—kidney cancer	5.02e-06	0.000162	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA9—kidney cancer	4.97e-06	0.00016	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.9e-06	0.000157	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	4.86e-06	0.000156	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.86e-06	0.000156	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—kidney cancer	4.86e-06	0.000156	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA9—kidney cancer	4.85e-06	0.000156	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.79e-06	0.000154	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PIK3CA—kidney cancer	4.76e-06	0.000153	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CRABP1—kidney cancer	4.74e-06	0.000152	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CRABP1—kidney cancer	4.71e-06	0.000151	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.64e-06	0.000149	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPAT—kidney cancer	4.64e-06	0.000149	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—kidney cancer	4.61e-06	0.000148	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA9—kidney cancer	4.53e-06	0.000146	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.52e-06	0.000145	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTP1—kidney cancer	4.49e-06	0.000144	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.43e-06	0.000142	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ITPR2—kidney cancer	4.4e-06	0.000142	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ITPR2—kidney cancer	4.38e-06	0.000141	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—FH—kidney cancer	4.31e-06	0.000139	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APRT—kidney cancer	4.31e-06	0.000139	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCB1—kidney cancer	4.25e-06	0.000137	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CRABP1—kidney cancer	4.23e-06	0.000136	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	4.22e-06	0.000136	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.16e-06	0.000134	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CRABP1—kidney cancer	4.13e-06	0.000133	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTM1—kidney cancer	4.12e-06	0.000133	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.06e-06	0.000131	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPC3—kidney cancer	4.06e-06	0.00013	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.04e-06	0.00013	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.02e-06	0.000129	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTT1—kidney cancer	4.02e-06	0.000129	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ACHE—kidney cancer	4.02e-06	0.000129	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTT1—kidney cancer	3.99e-06	0.000128	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ACHE—kidney cancer	3.99e-06	0.000128	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA2—kidney cancer	3.95e-06	0.000127	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ITPR2—kidney cancer	3.93e-06	0.000126	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1A1—kidney cancer	3.91e-06	0.000126	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CRABP1—kidney cancer	3.86e-06	0.000124	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALAD—kidney cancer	3.85e-06	0.000124	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ITPR2—kidney cancer	3.84e-06	0.000123	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SCARB1—kidney cancer	3.8e-06	0.000122	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SCARB1—kidney cancer	3.78e-06	0.000122	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS1—kidney cancer	3.76e-06	0.000121	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.75e-06	0.000121	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS1—kidney cancer	3.74e-06	0.00012	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PSMD7—kidney cancer	3.69e-06	0.000119	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PSMD7—kidney cancer	3.67e-06	0.000118	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.67e-06	0.000118	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAF1—kidney cancer	3.66e-06	0.000118	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.62e-06	0.000117	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTT1—kidney cancer	3.58e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ACHE—kidney cancer	3.58e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ITPR2—kidney cancer	3.58e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.52e-06	0.000113	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PGK1—kidney cancer	3.52e-06	0.000113	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ACHE—kidney cancer	3.5e-06	0.000112	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTT1—kidney cancer	3.5e-06	0.000112	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—BCHE—kidney cancer	3.5e-06	0.000112	CbGpPWpGaD
Vismodegib—ALB—Metabolism—BCHE—kidney cancer	3.48e-06	0.000112	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.46e-06	0.000111	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LDHB—kidney cancer	3.45e-06	0.000111	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC5A5—kidney cancer	3.44e-06	0.00011	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SCARB1—kidney cancer	3.39e-06	0.000109	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS1—kidney cancer	3.36e-06	0.000108	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.34e-06	0.000107	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A1—kidney cancer	3.32e-06	0.000107	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SCARB1—kidney cancer	3.31e-06	0.000106	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.3e-06	0.000106	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PSMD7—kidney cancer	3.29e-06	0.000106	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS1—kidney cancer	3.28e-06	0.000105	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—kidney cancer	3.28e-06	0.000105	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTT1—kidney cancer	3.27e-06	0.000105	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ACHE—kidney cancer	3.27e-06	0.000105	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.24e-06	0.000104	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.22e-06	0.000104	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PSMD7—kidney cancer	3.22e-06	0.000103	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	3.16e-06	0.000102	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—BCHE—kidney cancer	3.12e-06	0.0001	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SCARB1—kidney cancer	3.09e-06	9.95e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.08e-06	9.92e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS1—kidney cancer	3.06e-06	9.85e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—BCHE—kidney cancer	3.05e-06	9.8e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC5A5—kidney cancer	3.01e-06	9.68e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PSMD7—kidney cancer	3e-06	9.66e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA9—kidney cancer	2.99e-06	9.61e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.98e-06	9.58e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—kidney cancer	2.91e-06	9.37e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A1—kidney cancer	2.91e-06	9.35e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.89e-06	9.29e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—BCHE—kidney cancer	2.85e-06	9.16e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.82e-06	9.08e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.81e-06	9.04e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.81e-06	9.03e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—kidney cancer	2.79e-06	8.96e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTP1—kidney cancer	2.78e-06	8.95e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.77e-06	8.92e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTP1—kidney cancer	2.77e-06	8.9e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.72e-06	8.73e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.64e-06	8.47e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK3—kidney cancer	2.64e-06	8.47e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—kidney cancer	2.63e-06	8.47e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—kidney cancer	2.62e-06	8.42e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—kidney cancer	2.56e-06	8.22e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—kidney cancer	2.54e-06	8.18e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CRABP1—kidney cancer	2.54e-06	8.18e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.52e-06	8.1e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK1—kidney cancer	2.51e-06	8.06e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTP1—kidney cancer	2.48e-06	7.99e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTP1—kidney cancer	2.43e-06	7.8e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.42e-06	7.8e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—kidney cancer	2.41e-06	7.75e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KRAS—kidney cancer	2.37e-06	7.61e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ITPR2—kidney cancer	2.36e-06	7.6e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—kidney cancer	2.35e-06	7.56e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—kidney cancer	2.32e-06	7.47e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.3e-06	7.39e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—kidney cancer	2.28e-06	7.34e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTP1—kidney cancer	2.27e-06	7.28e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—kidney cancer	2.23e-06	7.17e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CA—kidney cancer	2.18e-06	7e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.16e-06	6.96e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTT1—kidney cancer	2.16e-06	6.93e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ACHE—kidney cancer	2.16e-06	6.93e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—kidney cancer	2.14e-06	6.9e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—kidney cancer	2.11e-06	6.79e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—kidney cancer	2.1e-06	6.77e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—kidney cancer	2.08e-06	6.69e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SCARB1—kidney cancer	2.04e-06	6.56e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTEN—kidney cancer	2.03e-06	6.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS1—kidney cancer	2.02e-06	6.49e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.99e-06	6.41e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.98e-06	6.37e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PSMD7—kidney cancer	1.98e-06	6.37e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.97e-06	6.35e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—BCHE—kidney cancer	1.88e-06	6.04e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.85e-06	5.96e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—kidney cancer	1.81e-06	5.81e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—kidney cancer	1.8e-06	5.78e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.79e-06	5.76e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.78e-06	5.72e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.62e-06	5.21e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—kidney cancer	1.61e-06	5.19e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—kidney cancer	1.58e-06	5.06e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTP1—kidney cancer	1.49e-06	4.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—kidney cancer	1.47e-06	4.73e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—kidney cancer	1.44e-06	4.64e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—kidney cancer	1.43e-06	4.61e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CA—kidney cancer	1.43e-06	4.6e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—kidney cancer	1.41e-06	4.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—kidney cancer	1.37e-06	4.41e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.3e-06	4.19e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—kidney cancer	1.29e-06	4.14e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTEN—kidney cancer	1.26e-06	4.04e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—kidney cancer	1.26e-06	4.04e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTEN—kidney cancer	1.25e-06	4.02e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—kidney cancer	1.17e-06	3.77e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTEN—kidney cancer	1.12e-06	3.61e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTEN—kidney cancer	1.1e-06	3.52e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTEN—kidney cancer	1.02e-06	3.29e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—kidney cancer	9.7e-07	3.12e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.87e-07	2.85e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CA—kidney cancer	8.82e-07	2.84e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.92e-07	2.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—kidney cancer	7.74e-07	2.49e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CA—kidney cancer	7.73e-07	2.49e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.22e-07	2.32e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTEN—kidney cancer	6.75e-07	2.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.76e-07	1.53e-05	CbGpPWpGaD
